Reframe Daily: Easier breast cancer surgery, lasting gene therapy, and a new way to “see” oxygen in skin

Reframe Daily—curated by Christin Chong (neuroscience PhD, Buddhist chaplain, healthtech strategy consultant)—delivers optimistic and credible healthtech updates you won’t find in most popular news outlets, from sources scientists and healthcare providers read and trust.

Today in one sentence: Doctors may be able to avoid a second underarm surgery for some early breast cancers; a single gene therapy for a rare immune disease stayed effective for years; lab studies suggest lower-dose steroids might still work for a severe kidney condition; researchers uncovered a microglia switch that could point to new MS drugs; and a new imaging tool maps oxygen use in skin, which could help wounds heal faster.

Pop in the Discord to chat about health →
https://forms.gle/tN3oabFTsDF21VnS8

Weekly personal shares from Christin here →
http://christin.substack.com/

Good news: Surgeons can safely avoid extra surgery for many patients with early breast cancer, which means fewer side effects and faster recovery.

Sentinel-Lymph-Node Biopsy Alone or with Completion Axillary Dissection?

Market readiness: 🙂🙂🙂🙂🙂 (existing surgical options; results can influence care immediately in the US). 

Good news: Children with a deadly immune disorder showed durable benefit years after gene therapy—evidence this one-time treatment can keep protecting them.

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency

Market readiness: 🙂🙂🙂🙂 (late-stage clinical data; not broadly FDA-approved yet but on a clear regulatory path). 

Good news: A study suggests doctors might be able to use lower steroid doses for a severe kidney inflammation while still getting strong effects—potentially fewer side effects.

Low-dose glucocorticoids attenuate crescentic glomerulonephritis

Market readiness: 🙂🙂 (preclinical/early translational evidence; drugs already exist but human trials needed for dosing change). 

Good news: Scientists found a sex-linked switch in brain immune cells that drives MS-like inflammation—pointing to a new, targetable pathway.

Deletion of the X-chromosomal gene Kdm6a in microglia …

Market readiness: 🙂 (basic mechanism in disease models; no human trial yet). 

Good news: A new oxygen-imaging method directly maps how skin tissues use oxygen, which could speed up testing of wound-healing and skin therapies.

Visualization of oxygen profile in reconstructed human epidermis by phosphorescence-lifetime imaging microscopy using an Ir(III) complex

Market readiness: 🙂🙂 (bench/skin-model demonstration of hardware-based diagnostic; clinical validation still ahead). 

Thank you for taking the time to take care of yourself and your loved ones.